CVS HEALTH CORPORATION Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CVS HEALTH CORPORATION (CVS) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $4.33 billion for the 12-month period ending 2022-12-31, per its 8-K filed 2023-05-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-05-25
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was $1.74B.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was $1.53B, a 10.00% increase year-over-year.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was $1.93B.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was $1.43B, a 42.99% increase year-over-year.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was $6.63B.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was -$596.00M, a 108.99% decline from fiscal 2017.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was $6.63B.
- CVS HEALTH CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was $5.23B, a 12.59% increase from fiscal 2014.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $4.33B 8-K · filed 2023-05-25 | $4.17B 10-K · filed 2023-02-08 | ||||||
| 2021-12-31 | $7.99B 8-K · filed 2023-05-25 | $7.90B 10-K · filed 2022-02-09 | ||||||
| 2020-12-31 | $7.20B 8-K · filed 2023-05-25 | |||||||
| 2019-12-31 | $1.74B 10-K · filed 2020-02-18 | $3.27B derived: sum of 2 quarters · filed 2020-02-18 | $5.20B derived: sum of 3 quarters · filed 2020-02-18 | $6.63B 10-K · filed 2022-02-09 | ||||
| 2019-09-30 | $1.53B 10-K · filed 2020-02-18 | $3.46B derived: sum of 2 quarters · filed 2020-02-18 | $4.89B 10-Q · filed 2019-11-06 | $4.46B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2019-06-30 | $1.93B 10-K · filed 2020-02-18 | $3.36B 10-Q · filed 2019-08-07 | $2.94B derived: sum of 3 quarters · filed 2020-02-18 | $4.33B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2019-03-31 | $1.43B 10-K · filed 2020-02-18 | $1.00B derived: sum of 2 quarters · filed 2020-02-18 | $2.40B derived: sum of 3 quarters · filed 2020-02-18 | -$167.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-12-31 | -$422.00M 10-K · filed 2020-02-18 | $968.00M derived: sum of 2 quarters · filed 2020-02-18 | -$1.59B derived: sum of 3 quarters · filed 2020-02-18 | -$596.00M 10-K · filed 2021-02-16 | ||||
| 2018-09-30 | $1.39B 10-K · filed 2020-02-18 | -$1.17B derived: sum of 2 quarters · filed 2020-02-18 | -$174.00M 10-Q · filed 2019-11-06 | $3.11B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-06-30 | -$2.56B 10-K · filed 2020-02-18 | -$1.56B 10-Q · filed 2019-08-07 | $1.72B derived: sum of 3 quarters · filed 2020-02-18 | $3.01B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-03-31 | $998.00M 10-K · filed 2020-02-18 | $4.29B derived: sum of 2 quarters · filed 2020-02-18 | $5.57B derived: sum of 3 quarters · filed 2020-02-18 | $6.67B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $3.29B 8-K · filed 2019-08-08 | $4.57B derived: sum of 2 quarters · filed 2019-08-08 | $5.67B derived: sum of 3 quarters · filed 2019-08-08 | $6.63B 10-K · filed 2020-02-18 | ||||
| 2017-09-30 | $1.28B 8-K · filed 2019-08-08 | $2.38B derived: sum of 2 quarters · filed 2019-08-08 | $3.34B 10-Q · filed 2018-11-06 | $5.05B derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2017-06-30 | $1.10B 8-K · filed 2019-08-08 | $2.06B 10-Q · filed 2018-08-08 | $3.77B derived: sum of 3 quarters · filed 2019-08-08 | $5.31B derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2017-03-31 | $962.00M 8-K · filed 2019-08-08 | $2.67B derived: sum of 2 quarters · filed 2019-08-08 | $4.21B derived: sum of 3 quarters · filed 2019-08-08 | $5.13B derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2016-12-31 | $1.71B 10-K · filed 2018-02-14 | $3.25B derived: sum of 2 quarters · filed 2018-02-14 | $4.17B derived: sum of 3 quarters · filed 2018-02-14 | $5.32B 8-K · filed 2019-08-08 | ||||
| 2016-09-30 | $1.54B 10-K · filed 2018-02-14 | $2.47B derived: sum of 2 quarters · filed 2018-02-14 | $3.61B 10-Q · filed 2017-11-06 | $5.11B derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-06-30 | $924.00M 10-K · filed 2018-02-14 | $2.07B 10-Q · filed 2017-08-08 | $3.57B derived: sum of 3 quarters · filed 2018-02-14 | $4.81B derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-03-31 | $1.15B 10-K · filed 2018-02-14 | $2.65B derived: sum of 2 quarters · filed 2018-02-14 | $3.88B derived: sum of 3 quarters · filed 2018-02-14 | $5.16B derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2015-12-31 | $1.50B 10-K · filed 2017-02-09 | $2.74B derived: sum of 2 quarters · filed 2017-02-09 | $4.01B derived: sum of 3 quarters · filed 2017-02-09 | $5.23B 10-K · filed 2018-02-14 | ||||
| 2015-09-30 | $1.24B 10-K · filed 2017-02-09 | $2.51B derived: sum of 2 quarters · filed 2017-02-09 | $3.73B 10-Q · filed 2016-11-08 | $5.05B derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $1.27B 10-K · filed 2017-02-09 | $2.49B 10-Q · filed 2016-08-02 | $3.81B derived: sum of 3 quarters · filed 2017-02-09 | $4.76B derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | $1.22B 10-K · filed 2017-02-09 | $2.54B derived: sum of 2 quarters · filed 2017-02-09 | $3.49B derived: sum of 3 quarters · filed 2017-02-09 | $4.74B derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2014-12-31 | $1.32B 10-K · filed 2016-02-09 | $2.27B derived: sum of 2 quarters · filed 2016-02-09 | $3.52B derived: sum of 3 quarters · filed 2016-02-09 | $4.64B 10-K · filed 2017-02-09 | ||||
| 2014-09-30 | $948.00M 10-K · filed 2016-02-09 | $2.19B derived: sum of 2 quarters · filed 2016-02-09 | $3.32B 10-Q · filed 2015-10-30 | $4.59B derived: sum of 4 quarters · filed 2016-02-09 | ||||
| 2014-06-30 | $1.25B 10-K · filed 2016-02-09 | $2.38B 10-Q · filed 2014-08-05 | $3.64B derived: sum of 3 quarters · filed 2016-02-09 | $4.90B derived: sum of 4 quarters · filed 2016-02-09 | ||||
| 2014-03-31 | $1.13B 10-K · filed 2016-02-09 | $2.40B derived: sum of 2 quarters · filed 2016-02-09 | $3.65B derived: sum of 3 quarters · filed 2016-02-09 | $4.78B derived: sum of 4 quarters · filed 2016-02-09 | ||||
| 2013-12-31 | $1.27B 10-K · filed 2015-02-10 | $2.52B derived: sum of 2 quarters · filed 2015-02-10 | $3.65B derived: sum of 3 quarters · filed 2015-02-10 | $4.60B 10-K · filed 2016-02-09 | ||||
| 2013-09-30 | $1.25B 10-K · filed 2015-02-10 | $1.26B 10-Q · filed 2013-11-05 | $2.38B derived: sum of 2 quarters · filed 2015-02-10 | $3.33B 10-Q · filed 2014-11-04 | $3.34B 10-Q · filed 2013-11-05 | $4.46B derived: sum of 4 quarters · filed 2015-02-10 | ||
| 2013-06-30 | $1.13B 10-K · filed 2015-02-10 | $1.12B 10-Q · filed 2013-08-06 | $2.08B 10-Q · filed 2014-08-05 | $2.08B 10-Q · filed 2013-08-06 | $3.20B derived: sum of 3 quarters · filed 2015-02-10 | $4.21B derived: sum of 4 quarters · filed 2015-02-10 | ||
| 2013-03-31 | $954.00M 10-K · filed 2015-02-10 | $956.00M 10-Q · filed 2013-05-01 | $2.08B derived: sum of 2 quarters · filed 2015-02-10 | $3.09B derived: sum of 3 quarters · filed 2015-02-10 | $4.05B derived: sum of 4 quarters · filed 2015-02-10 | |||
| 2012-12-31 | $1.13B 10-K · filed 2014-02-11 | $1.13B 10-K · filed 2013-02-15 | $2.13B derived: sum of 2 quarters · filed 2014-02-11 | $3.10B derived: sum of 3 quarters · filed 2014-02-11 | $3.87B 10-K · filed 2015-02-10 | $3.88B 10-K · filed 2013-02-15 | ||
| 2012-09-30 | $1.01B 10-K · filed 2014-02-11 | $1.01B 10-Q · filed 2012-11-06 | $1.97B derived: sum of 2 quarters · filed 2014-02-11 | $2.75B 10-Q · filed 2013-11-05 | $3.84B derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-06-30 | $962.00M 10-K · filed 2014-02-11 | $966.00M 10-Q · filed 2012-08-07 | $1.74B 10-Q · filed 2013-08-06 | $2.83B derived: sum of 3 quarters · filed 2014-02-11 | $3.70B derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-03-31 | $772.00M 10-K · filed 2014-02-11 | $776.00M 10-Q · filed 2012-05-02 | $1.87B derived: sum of 2 quarters · filed 2014-02-11 | $2.74B derived: sum of 3 quarters · filed 2014-02-11 | $3.55B derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2011-12-31 | $1.10B 10-K · filed 2013-02-15 | $1.97B derived: sum of 2 quarters · filed 2013-02-15 | $2.78B derived: sum of 3 quarters · filed 2013-02-15 | $3.49B 10-K · filed 2014-02-11 | $3.49B 10-K · filed 2012-02-17 | |||
| 2011-09-30 | $867.00M 10-K · filed 2013-02-15 | $1.68B derived: sum of 2 quarters · filed 2013-02-15 | $2.39B 10-Q · filed 2012-11-06 | $3.41B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $813.00M 10-K · filed 2013-02-15 | $816.00M 10-Q · filed 2011-08-04 | $1.52B 10-Q · filed 2012-08-07 | $1.53B 10-Q · filed 2011-08-04 | $2.54B derived: sum of 3 quarters · filed 2013-02-15 | $3.36B derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2011-03-31 | $709.00M 10-K · filed 2013-02-15 | $713.00M 10-Q · filed 2011-05-05 | $1.73B derived: sum of 2 quarters · filed 2013-02-15 | $2.54B derived: sum of 3 quarters · filed 2013-02-15 | $3.36B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $1.02B 10-K · filed 2012-02-17 | $1.03B 10-K · filed 2011-02-18 | $1.83B derived: sum of 2 quarters · filed 2012-02-17 | $2.65B derived: sum of 3 quarters · filed 2012-02-17 | $3.42B 10-K · filed 2013-02-15 | $3.44B 10-K · filed 2011-02-18 | ||
| 2010-09-30 | $815.00M 10-K · filed 2012-02-17 | $819.00M 10-Q · filed 2010-11-03 | $1.63B derived: sum of 2 quarters · filed 2012-02-17 | $2.40B 10-Q · filed 2011-11-03 | $2.41B 10-Q · filed 2010-11-03 | $3.45B derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-06-30 | $819.00M 10-K · filed 2012-02-17 | $822.00M 10-Q · filed 2010-07-29 | $1.59B 10-Q · filed 2011-08-04 | $2.64B derived: sum of 3 quarters · filed 2012-02-17 | $3.66B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $768.00M 10-K · filed 2012-02-17 | $772.00M 10-K · filed 2011-02-18 | $1.82B derived: sum of 2 quarters · filed 2012-02-17 | $2.84B derived: sum of 3 quarters · filed 2012-02-17 | $3.73B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | $1.05B 10-K · filed 2011-02-18 | $2.07B derived: sum of 2 quarters · filed 2011-02-18 | $2.96B derived: sum of 3 quarters · filed 2011-02-18 | $3.70B 10-K · filed 2012-02-17 | $3.71B 10-K · filed 2011-02-18 | |||
| 2009-09-30 | $1.02B 10-K · filed 2011-02-18 | $1.91B derived: sum of 2 quarters · filed 2011-02-18 | $2.66B 10-Q · filed 2010-11-03 | |||||
| 2009-06-30 | $890.00M 10-K · filed 2011-02-18 | $889.00M 10-Q · filed 2010-07-29 | $1.63B 10-Q · filed 2010-07-29 | |||||
| 2009-03-31 | $744.00M 10-K · filed 2011-02-18 | |||||||
| 2008-12-31 | $3.34B 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |